Abstract The 2022 World Health Organization (WHO) classification of the urinary and male
genital tumors was recently published by the International Agency for Research on Cancer …

The natural history of cancers can be understood through the lens of evolution given that the
driving forces of cancer development are mutation and selection of fitter clones. Cancer …

Artificial intelligence (AI) has shown promise for diagnosing prostate cancer in biopsies.
However, results have been limited to individual studies, lacking validation in multinational …

Background High rates of overdiagnosis are a critical barrier to organized prostate cancer
screening. Magnetic resonance imaging (MRI) with targeted biopsy has shown the potential …

Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

Histopathological images contain rich phenotypic information that can be used to monitor
underlying mechanisms contributing to disease progression and patient survival outcomes …

Background An increasing volume of prostate biopsies and a worldwide shortage of
urological pathologists puts a strain on pathology departments. Additionally, the high intra …

Five years after the last prostatic carcinoma grading consensus conference of the
International Society of Urological Pathology (ISUP), accrual of new data and modification of …

Background There is growing interest to implement multiparametric magnetic resonance
imaging (mpMRI) and MR-guided biopsy (MRGB) for biopsy-naïve men with suspected …

Background The use of 12-core systematic prostate biopsy is associated with diagnostic
inaccuracy that contributes to both overdiagnosis and underdiagnosis of prostate cancer …